Rhythmical Massage Therapy for Constipation

Conrad Lorenz

Last update: 18.07.2019

The general approach to treatment of constipation with rhythmical massage therapy includes promoting peristaltic function in the metabolic area, loosening cramped abdominal, lumbar and neck muscles, building strength, stabilizing the cardiovascular system, conveying calm and relaxation, and enabling a coherent experience of the body in the sense of: I feel comfortable in my body.

The therapeutic approach

  • Abdominal massages
    The therapist forms her gestures thoroughly and intensively, especially in the releasing phase.
    Targeted use of friction and vibration to activate intestinal peristalsis.
    Solar plexus strokes with
    Oxalis e planta tota W 10% oil WALA if there is pain 

  • Efferent treatment of the neck
    To stimulate and enliven, according to the polarity principle: back-above, front-below.

  • Pelvis treatment
    To warm the nerve plexus in the area of the anus: thorough, deep kneading of the gluteal muscles, with intense friction in the area between the iliac crest and the lumbar spine.

  • Leg massages, possibly a hip treatment in a lateral position
    Sculpted, efferent leg treatments to promote excretion and regulation of congestion.

  • Rhythmical embrocation of the kidneys. If necessary, the patient can lie on one side:
    Argentum metallicum praep. 0.4% ointment WELEDA or peat oil with silver WANDIL (available as Torföl mit Silber) or
    peat oil with Equisetum WANDIL (available as Torföl mit Equisetum).
    To generally stimulate organ function use
    Red Copper Ointment WALA (also available as Kupfer Salbe rot) or peat oil with copper WANDIL (available as Torföl mit Kupfer).


  • Abdominal compresses with carraway oil
    have also proven to be a valuable therapeutic aid and can be used in combination before or after treatment. 

Research news

Mistletoe therapy in addition to standard immunotherapy in patients with non-small-cell lung cancer indicates improved survival rates 
Immunotherapy with PD-1/PD-L1 inhibitors has significantly improved the survival rates of patients with metastatic non-small-cell lung cancer (NSCLC). Results of a real-world data study (RWD) investigating the addition of Viscum album L. (VA) to chemotherapy have shown an association with improved survival in patients with NSCLC - regardless of age, degree of metastasis, performance status, lifestyle or oncological treatment. The mechanisms may include synergistic modulations of the immune response by PD-1/PD-L1 inhibitors and VA. However, the results should be taken with caution due to the observational and non-randomised study design. The study has been published open access in Cancers
https://doi.org/10.3390/cancers16081609.


Further information on Anthroposophic Medicine